INGA BENNETT: Open Payments
NPI 1417400318 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,003 in 102 payments from 16 companies in 2025. Trend: 2023 $3,007 · 2024 $2,781 · 2025 $2,003
Food & beverage: $1,903Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $344 |
| Galderma Laboratories, L.P. | 15 | $265 |
| Janssen Biotech, Inc. | 14 | $250 |
| ABBVIE INC. | 19 | $199 |
| Organon LLC | 7 | $161 |
| PFIZER INC. | 6 | $111 |
| Novartis Pharmaceuticals Corporation | 4 | $110 |
| Lilly USA, LLC | 4 | $98 |
| E.R. Squibb & Sons, L.L.C. | 3 | $86 |
| Incyte Corporation | 3 | $84 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, SKYRIZI, VTAMA, CIBINQO, COSENTYX, Sotyktu.
Industry payments across GA — which companies pay providers there.
